Cost-Minimization Analysis of Alternative Diagnostic Approaches in a Modeled Patient With Non-Small Cell Lung Cancer and Subcarinal Lymphadenopathy
- 28 February 2002
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 77 (2), 155-164
- https://doi.org/10.4065/77.2.155
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Survival of Patients With Resected N2 Non–Small-Cell Lung Cancer: Evidence for a Subclassification and ImplicationsJournal of Clinical Oncology, 2000
- Results of surgical treatment of non–small cell lung cancer: validation of the new postoperative pathologic tnm classificationThe Journal of Thoracic and Cardiovascular Surgery, 2000
- How should interlobar pleural invasion be classified? prognosis of resected T3 non-small cell lung cancerThe Annals of Thoracic Surgery, 1999
- Prognosis of completely resected pn2 non–small cell lung carcinomas: What is the significant node that affects survival?The Journal of Thoracic and Cardiovascular Surgery, 1999
- The prognosis of surgically resected N2 non–small cell lung cancer: The importance of clinical N statusThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Imaging of mediastinal lymph nodes: CT, MR, and FDG PET.RadioGraphics, 1998
- Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 casesThe Annals of Thoracic Surgery, 1997
- Combined pulmonary and thoracic wall resection for stage III lung cancer.Thorax, 1995
- Chest CT for Known or Suspected Lung CancerChest, 1994
- CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group.Radiology, 1991